Emergent Biosolutions (EBS) Institutional Ownership

78.40% of Emergent Biosolutions' stock is owned by institutional investors. Learn more on EBS's institutional investor holdings.

Of the 157 institutional investors that purchased Emergent Biosolutions' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($4.72M), State Street Corp ($1.96M), Millennium Management LLC ($1.85M), Ancora Advisors LLC ($1.73M), Dimensional Fund Advisors LP ($1.35M), Oak Hill Advisors LP ($1.11M), and Jain Global LLC ($942.69K).

Institutional investors have bought a total of 15,256,607 shares in the last 24 months. This purchase volume represents approximately $140.54M in transactions.

Of the 49 institutional investors that sold Emergent Biosolutions' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($677.61K), Invesco Ltd. ($359.27K), Marshall Wace LLP ($275.39K), Jump Financial LLC ($271.86K), Assenagon Asset Management S.A. ($254.59K), Trexquant Investment LP ($224.60K), and Bank of America Corp DE ($220.45K).

Institutional investors have sold a total of 3,758,623 shares in the last 24 months. This volume of shares sold represents approximately $38.38M in transactions.